News

3 ways the GLP-1 market has changed shape this year
The obesity market still only has two clear leaders with approved GLP-1 medications, and frontrunners Eli Lilly and Novo ...
If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today
One thousand dollars invested three years ago is now worth an incredible $10,640 as of Aug. 11. Where to invest $1,000 right now? Our analyst team just revealed what they believe ...
Eli Lilly’s daily GLP-1 pill shows strong weight loss results without food restrictions
Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an ...